BBMRI/ELIXIR Working Group Statement Sample Clauses

BBMRI/ELIXIR Working Group Statement. 16-17 Nov 2009‌ BBMRI Goal: BBMRI’s mission is to construct a pan-European biobanking infrastructure, building on existing infrastructure, resources and technologies, specifically complemented with innovative components and properly embedded into European ethical, legal and societal frameworks. ELIXIR Goal: To construct and operate a sustainable infrastructure for biological information in Europe, to support life science research and its translation to medicine and the environment, the bio-industries and society. There is a critical need to analyse and define the landscape and the communication channels between biobank resources, which will be federated under BBMRI and the integrated public data resources (such as the human genome in Ensembl), which are the responsibility of ELIXIR. This challenge is large and incorporates standards, synonyms, data and process security; XXXX (Ethical Legal and Societal Issues) etc. To address this challenge and to make concrete steps going forward we have established a joint working group. The remit of this group will be: • To understand and define the landscape for linkage, access and common querying between the biobanks and the public domain biomolecular resources (e.g., Ensembl Genome sequences) • To analyse researchers’ requirements for linking of resources to generate knowledge • To encourage the development and adoption of common protocols from ‘needle to freezer’ and of a seamless provenance and quality management systemTo ensure that the same descriptions (metadata) are employed (or mappings provided) throughout for sample management • To address the security issues which are relevant to the collaboration between BBMRI and ELIXIR, e.g., personal data and samples • To promote and develop technical solutions to link between published results, ‘raw’ data and provenance o For access o For encouragement to publish/share raw dataTo provide guidance for the software solutions which will need to be developed to solve these problems, promoting open source solutions • Establish a dialogue with stakeholders Members of the BBMRI/ELIXIR Working Group: BBMRI: Xxxxx Xxxx, Xxxxxx Xxxx, Xxx-Xxxx Xxxxxx, Xxxx Xxxxxxx-Xxxxxxx, Xxxxxx Xxxxxxxx, Xxxx Xxxxxx, Xxxx Xxxxxxx, Xxxxxx Xxxxxx ELIXIR: Xxxx Xxxxxx, Xxxxx Xxxxxx, Xxxxx Xxxxxxxxxx, Xxxxxx Xxxxx, Xxxxxx Xxxxxx, Xxxxx Xxxxxxxx, Xxxxx Xxxxxxxxxxx 2 Deliverables and milestones tables‌ 2.1 Deliverables (excluding the periodic and final reports)‌ TABLE 1. DELIVERABLES1 D5.1 Inven...
AutoNDA by SimpleDocs
BBMRI/ELIXIR Working Group Statement. 16-17 Nov 2009 2.1 Deliverables (excluding the periodic and final reports)

Related to BBMRI/ELIXIR Working Group Statement

  • Development Reports Beginning six months after Effective Date and ending on the date of first commercial sale of a Licensed Product in the United States, LICENSEE shall report to Cornell progress covering LICENSEE's (and Affiliate's and Sublicensee's) activities and efforts in the development of rights granted to LICENSEE under this Agreement for the preceding six months. The report shall include, but not be limited to, activities and efforts to develop and test all Licensed Products and obtain governmental approvals necessary for marketing the same. Such semi-annual reports shall be due within sixty days (60) of the reporting period and shall use the form as provided herein as Appendix C.

  • Business Plan and Budget As soon as available, but in any event within sixty (60) days after the end of each fiscal year of the Borrower, an annual business plan and budget of the Borrower and its Subsidiaries on a Consolidated basis, including forecasts prepared by management of the Borrower, in form reasonably satisfactory to the Lender, of Consolidated balance sheets and statements of income or operations and cash flows of the Borrower and its Subsidiaries on a fiscal year basis and, in the case of such forecasted statements of income, on a fiscal quarterly basis for the immediately following fiscal year. As to any information contained in materials furnished pursuant to Section 6.02(f), the Borrower shall not be separately required to furnish such information under Section 6.01(a) or (b) above, but the foregoing shall not be in derogation of the obligation of the Borrower to furnish the information and materials described in Sections 6.01(a) and (b) above at the times specified therein.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Development Schedule The Project shall substantially comply with the specific timetables and triggers for action set forth in Article 5 of this Agreement. The parties acknowledge that, as provided in G.S. 160A-400.25(b), the failure to meet a commencement or completion date shall not, in and of itself, constitute a material breach of this Agreement pursuant to G.S. 160A-400.27 but must be judged based upon the totality of the circumstances.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Program Budget A) Contractor will expend funds received for operation of its program and services according to Contractor’s annual operating budget. The portions of said budget, which reflect services performed or money paid to Contractor pursuant to this Agreement shall be subject to the approval of the Human Services Agency. B) In the event Contractor determines a reasonable business necessity to transfer funding between personnel and operating expenses specified in the budget submitted to the Human Services Agency the following will apply: 1. Contractor will notify the Human Services Agency of transfers that in the aggregate are between ten percent (10%) and twenty percent (20%) of the maximum contract amount.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Budget Consulting Engineer/Architect shall advise City if, in its opinion, the amount budgeted for construction is not sufficient to adequately design and construct the improvement as requested.

  • Development Budget Attached hereto as Exhibit "B" and incorporated herein by this reference is the Development Budget in an amount equal to $_____________. Owner acknowledges and represents that the attached Development Budget includes the total costs and expenses to acquire, develop, renovate and construct the Real Property and the Apartment Housing.

  • Development Records Each Party shall maintain complete, current and accurate records of all Development activities conducted by it hereunder, and all data and other information resulting from such activities. Such records shall fully and properly reflect all work done and results achieved in the performance of the Development activities in good scientific manner appropriate for regulatory and patent purposes. Each Party shall document all non-clinical studies and Clinical Trials in formal written study reports according to Applicable Laws and national and international guidelines (e.g., ICH, cGCP, cGLP, and cGMP).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!